Despite the fact that the majority of the studies have focused on the reduced β-adrenergic responsiveness as a consequence of increased GRK2 expression in cardiac hypertrophy and heart failure [141,142], there are a number of studies showing decreased expression of GRK2 in the ischemic myocardium [143]. Here, GRK2 is linked to cardiac hypertrophy.